Patent ID: 11931367
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  G | IPC A  G

Claim 53:
54. The method of claim 1, wherein if after administration of said at least one dose of said initial dosage, a steady state androst-4-en-17β-ol-3-one serum concentration level of said subject exceeds a predetermined level, said at least one dose of said maintenance dosage subceeds said at least one dose of said initial dosage, and wherein if a steady state androst-4-en-17β-ol-3-one serum concentration level of said subject subceeds a predetermined level, said at least one dose of said maintenance dosage exceeds said at least one dose of said initial dosage, and wherein if a steady state androst-4-en-17β-ol-3-one serum concentration level is within a predetermined range, an amount of said at least one dose of said maintenance dosage is substantially identical to the amount of at least one previously administered dose, and wherein said administration results in a Cavg responder rate that is greater than a Cavg responder rate of an administration to subjects of a substantially similar but untitrated dosage regimen of a pharmaceutical composition comprising (17-β)-3-oxoandrost-4-en-17-yl tridecanoate.